AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Sep 18, 2025
35172_dirs_2025-09-18_8c44afa6-eb36-4f43-b01b-d46b822eb5d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-07-24
Reporting Person: Young David (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 217332 | Direct |
| Common Stock | 30985 | Indirect |
| Common Stock | 10786 | Indirect |
| Common Stock | 18544 | Indirect |
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15